Immunomodulatory Effects of Dioscoreae Rhizome Against Inflammation through Suppressed Production of Cytokines Via Inhibition of the NF- Pathway |
Kim, Seulah
(College of Pharmacy, Sahmyook University)
Shin, Seulmee (College of Pharmacy, Sahmyook University) Hyun, Bobae (College of Pharmacy, Sahmyook University) Kong, Hyunseok (College of Pharmacy, Sahmyook University) Han, Shinha (College of Pharmacy, Sahmyook University) Lee, Aeri (College of Pharmacy, Sahmyook University) Lee, Seungjeong (College of Pharmacy, Chungbuk University) Kim, Kyungjae (College of Pharmacy, Sahmyook University) |
1 | Lee, G. I., J. Y. Ha, K. R. Min, H. Nakagawa, S. Tsurufuji, I. M. Chang, and Y. Kim. 1995. Inhibitory effects of oriental herbal medicines on IL-8 induction in lipopolysaccharideactivated rat macrophages. Planta. Med. 61: 26-30. |
2 | Laskin, D. L. and K. J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35: 655-677. |
3 | Furchgott, R., P. Cherry, J. Zawadzki, and D. Jothianandan. 1984. Endothelial cells as mediators of vasodilation of arteries. J. Cardiovasc. Pharmacol. 6: S336-343. |
4 | Wei, X., I. Charles, A. Smith, J. Ure, G. Feng, and H. Huang. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-4011. |
5 | Ahmad, N., L. C. Chen, M. A. Gordon, J. D. Laskin, and D. L. Laskin. 2002. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukoc. Biol. 71: 1005-1011. |
6 | Li, Q. and I. M. Verma. 2002. NFkappa B regulation in the immune system. Nat. Rev. Immunol. 2: 725-734. |
7 | Richmond, A. 2002. NF-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2: 664-674. |
8 | Lee, S., S. Shin, H. Kim, S. Han, K. Kim, J. Kwon, J. H. Kwak, C. K. Lee, N. J. Ha, D. Yim, and K. Kim. 2011. Antipinflammatory function of arctiin by inhibiting COX-2 expression via NF-kappaB pathways. Inflammation 8: 16. |
9 | Karin, M. and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: The control of NF-kappa B activity. Annu. Rev. Immunol. 18: 621-663. |
10 | Stuehr, D. J. and C. F. Nathan. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543-1555. |
11 | Duncan, B. B., M. I. Schmidt, J. S. Pankow, C. M. Ballantyne, D. Couper, A. Vigo, R. Hoogeveen, A. R. Folsom, and G. Heiss; Atherosclerosis Risk in Communities Study. 2003. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805. |
12 | Jacobs, M., M. M. van Greevenbroek, C. J. van der Kallen, I. Ferreira, E. E. Blaak, E. J. Feskens, E. H. Jansen, C. G. Schalkwijk, and C. D. Stehouwer. 2009. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur. J. Clin. Invest. 39: 437-444. |
13 | Vane, J. R., J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91: 2046-2050. |
14 | Lee, T. H., H. B. Kwak, H. H. Kim, Z. H. Lee, D. K. Chung, N. I. Baek, and J. Kim. 2007. Methanol extracts of Stewartia koreana inhibit cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) gene expression by blocking NF-kappaB transactivation in LPS-activated RAW 264.7 cells. Mol. Cells 23: 398-404. |
15 | Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100: 2417-2423. |
16 | Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2: 907-916. |
17 | Vila-del Sol, V. and M. Fresno. 2005. Involvement of TNF and NF-kappa B in the transcriptional control of cyclooxygenase- 2 expression by IFN-gamma in macrophages. J. Immunol. 174: 2825-2833. |
18 | Lind, L. 2003. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169: 203-214. |
19 | Tilg, H., A. Wilmer, W. Vogel, M. Herold, B. Nölchen, G. Judmaier, and C. Huber. 1992. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103: 264-274. |
20 | Coker, R. K. and G. J. Laurent. 1998. Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 11: 1218-1221. |
21 | Zhong, X., E. Nishino, and N, Okagami. 2002. Temperature dependence of seedling establishment of a perennial, Dioscorea tokoro. J. Plant. Res. 115: 55-57. |
22 | Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell. Biol. 10: 405-455. |
23 | Renard, P. and M. Raes. 1999. The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies. Cell. Biol. Toxicol. 15: 341-344. |
24 | Tian, B. and A. R. Brasier. 2003. Identification of a nuclear factor kappa B-dependent gene network. Recent. Prog. Horm. Res. 58: 95-130. |
25 | Lee, S. C., C. C. Tsai, J. C. Chen, C. C. Lin, M. L. Hu, and S. Lu. 2002. The evaluation of reno- and hepatoprotective effects of huai-shan-yao (Rhizome Dioscoreae). Am. J. Chin. Med. 30: 609-616. |
26 | Tewtrakul, S. and A. Itharat. 2007. Nitric oxide inhibitory substances from the rhizomes of Dioscorea membranacea. J. Ethnopharmacol. 109: 412-416. |